Orbit Genomics

IMIDEX and Orbit Genomics have partnered to address the challenge of early lung cancer detection. Imidex’s AI-driven chest x-ray technology identifies lung nodules with 83% sensitivity, offering a broader screening reach compared to traditional methods. Orbit Genomics then provides deeper genomic insights through its OrbiSeq-L platform, helping to clarify indeterminate findings. This collaboration is designed to bridge the gap in lung cancer diagnosis by combining advanced imaging with targeted genomics. Read more about how this partnership could impact early diagnosis and patient outcomes: https://lnkd.in/e3N7UfM5 #Bioengineering #LungCancer #AI #Healthcare #PrecisionMedicine Wes Bolsen Dede Willis

?? It’s graduation day for CancerX’s Accelerator program's inaugural cohort of startups! For four months, The Blue Box Biomedical Solutions, C the Signs, Cancer Insights, Curiva, EnteroTrack LLC., Gesund.ai, Gray Oncology Solutions, Lind, Mika, Navya Care, Oatmeal Health, Orbit Genomics, Realyze Intelligence, Reimagine Care, SurvivorPlan, XanthosHealth, collaborated with Accelerator Champions, Mentors, federal partners, and CancerX members across the healthcare ecosystem to generate and scale ideas that have the potential to save lives and improve the experience of cancer patients and their caregivers—both strongly tied to CancerX and the Cancer Moonshot goals. The startups shared ideas for digital innovation in clinical research, screening and diagnosis, treatment and management, clinical operations, and patient, caregiver, and survivor experience, and were selected from a strong pool of over 100 startup applicants. Judging for the CancerX Accelerator was led by Moffitt Cancer Center and MassChallenge alongside CancerX Accelerator Champions Atrium Health, AstraZeneca, Amazon Web Services (AWS), Debiopharm, Dell Technologies, Intel Corporation, Oncology Ventures, Reveal HealthTech, and UC Davis Health with insight and observation by our federal partners. By graduating from the Accelerator program, these startups now have a roadmap to successfully scale their company, an opportunity to move forward with their sponsor, and a strong community supporting their development. And with 16 empowered startups poised for success and equipped with the tools and expertise needed to bring their ideas to life, significant strides are being made in revolutionizing the fight against cancer through digital innovation. ?? Please join us in recognizing and celebrating these Startups, their Champions, and Mentors, and the incredible impact of their progress in CancerX’s mission to unleash the power of innovation to reduce the burden of cancer for everyone. We’re thrilled to offer you the chance to be involved in our next cohort! Submissions for Cohort 2025 will open soon, and if you want to join the CancerX Accelerator as a Startup, Champion, or Mentor, be the first to hear about the details for Cohort 2025 by signing up here: https://lnkd.in/ebpXGwXa

?????? We are thrilled to announce the inaugural cohort of startups in our Accelerator, launched in partnership with MassChallenge https://lnkd.in/gXd42i-8 The Blue Box Biomedical Solutions, Curiva, C the Signs, Cancer Insights , EnteroTrack LLC., Gesund.ai, Gray Oncology Solutions, LIND AI, Mika, Navya Care, Oatmeal Health, Orbit Genomics, Realyze Intelligence, Reimagine Care, SurvivorPlan, and XanthosHealth. ?? Just now shared on stage at #ViVE2024, this group was selected from a robust list of startup applicants who shared their ideas for #digitalinnovation – in the area of clinical trials; screening and diagnosis; treatment and management; clinical operations; or patient, caregiver, and survivor experience – aiming to reduce the burden of #cancer for all people. ?? A team of Accelerator Champions, including Debiopharm and Reveal HealthTech, alongside judges from the CancerX community, led three rounds of judging in January to select this cohort group. ?? Let’s give a big round of applause to these digital health innovators! They will now participate in a rich, 4-month program where they will: ?? Engage with members of the healthcare ecosystem to test and validate their solutions. ?? Get expert guidance from CancerX Mentors. ?? Graduate with a roadmap to successfully scale their company, an opportunity to move forward with their sponsor, and a community that will continue to support their development. ?? Sign up to hear the latest news from the Accelerator’s first cohort, as well as other CancerX updates: https://lnkd.in/ec29r7HU Digital Medicine Society (DiMe) Moffitt Cancer Center Office of the National Coordinator for Health Information Technology (ONC) Office of the Assistant Secretary for Health (OASH)

?????? We are thrilled to announce the inaugural cohort of startups in our Accelerator, launched in partnership with MassChallenge https://lnkd.in/gXd42i-8 The Blue Box Biomedical Solutions, Curiva, C the Signs, Cancer Insights , EnteroTrack LLC., Gesund.ai, Gray Oncology Solutions, LIND AI, Mika, Navya Care, Oatmeal Health, Orbit Genomics, Realyze Intelligence, Reimagine Care, SurvivorPlan, and XanthosHealth. ?? Just now shared on stage at #ViVE2024, this group was selected from a robust list of startup applicants who shared their ideas for #digitalinnovation – in the area of clinical trials; screening and diagnosis; treatment and management; clinical operations; or patient, caregiver, and survivor experience – aiming to reduce the burden of #cancer for all people. ?? A team of Accelerator Champions, including Debiopharm and Reveal HealthTech, alongside judges from the CancerX community, led three rounds of judging in January to select this cohort group. ?? Let’s give a big round of applause to these digital health innovators! They will now participate in a rich, 4-month program where they will: ?? Engage with members of the healthcare ecosystem to test and validate their solutions. ?? Get expert guidance from CancerX Mentors. ?? Graduate with a roadmap to successfully scale their company, an opportunity to move forward with their sponsor, and a community that will continue to support their development. ?? Sign up to hear the latest news from the Accelerator’s first cohort, as well as other CancerX updates: https://lnkd.in/ec29r7HU Digital Medicine Society (DiMe) Moffitt Cancer Center Office of the National Coordinator for Health Information Technology (ONC) Office of the Assistant Secretary for Health (OASH)